Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

H Quitian; P Aschner; O Muñoz; N Iragorri; D Girón; C Gomez-Restrepo; D Rosselli

doi:10.1016/j.jval.2015.09.2104

Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

Translated title of the contribution: Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

H Quitian, P Aschner, O Muñoz, N Iragorri, D Girón, C Gomez-Restrepo, D Rosselli

Pontificia Universidad Javeriana

Research output: Contribution to journal › Meeting Abstract › peer-review

Translated title of the contribution	Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia
Original language	Spanish
Pages (from-to)	A608-A609
Number of pages	2
Journal	Value in Health
Volume	18
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2015.09.2104
State	Published - Nov 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jval.2015.09.2104

Cite this

@article{fdd4d620ad5442f397711743f42cba35,

title = "Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia",

author = "H Quitian and P Aschner and O Mu{\~n}oz and N Iragorri and D Gir{\'o}n and C Gomez-Restrepo and D Rosselli",

year = "2015",

month = nov,

doi = "10.1016/j.jval.2015.09.2104",

language = "Espa{\~n}ol ",

volume = "18",

pages = "A608--A609",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

AU - Quitian, H

AU - Aschner, P

AU - Muñoz, O

AU - Iragorri, N

AU - Girón, D

AU - Gomez-Restrepo, C

AU - Rosselli, D

PY - 2015/11

Y1 - 2015/11

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_puj3&SrcAuth=WosAPI&KeyUT=WOS:000209861300576&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/j.jval.2015.09.2104

DO - 10.1016/j.jval.2015.09.2104

M3 - Resumen de la jornada

SN - 1098-3015

VL - 18

SP - A608-A609

JO - Value in Health

JF - Value in Health

IS - 7

ER -

Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

UN SDGs

Access to Document

Other files and links

Cite this